Egetis Therapeutics
Develops and commercializes treatments for serious and rare diseases.
EGTX | ST
Overview
Corporate Details
- ISIN(s):
- SE0003815604
- LEI:
- 549300RZCKGWRUBPMY22
- Country:
- Sweden
- Address:
- Klara Norra Kyrkogata 26, 111 22 Stockholm
- Website:
- https://www.egetis.com/
- Sector:
- Manufacturing
Description
Egetis Therapeutics is an innovative and integrated pharmaceutical company focused on developing and commercializing treatments for serious and rare diseases with significant unmet medical needs. The company's strategy centers on advancing drug candidates through late-stage clinical development to market approval. Its primary asset, Emcitate (tiratricol), is a first-in-class drug candidate in late-stage development for the treatment of Monocarboxylate Transporter 8 (MCT8) deficiency, a rare congenital disorder of thyroid hormone transport.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-04-06 08:30 |
PledPharma avslutar fas III-programmet POLAR i det tredje kvartalet
|
Swedish | 154.9 KB | ||
| 2020-03-30 10:30 |
Publicering av PledPharmas årsredovisning för 2019
|
Swedish | 55.0 KB | ||
| 2020-03-30 10:30 |
PledPharma’s 2019 annual report published
|
English | 51.2 KB | ||
| 2020-03-30 10:30 | Swedish | 5.6 MB | |||
| 2020-03-25 18:30 |
KALLELSE TILL ÅRSSTÄMMA I PLEDPHARMA AB
|
English | 107.1 KB | ||
| 2020-03-25 18:30 |
KALLELSE TILL ÅRSSTÄMMA I PLEDPHARMA AB
|
Swedish | 106.6 KB | ||
| 2020-03-01 23:59 |
PledPharma pausar dosering av patienter i POLAR programmet
|
Swedish | 167.5 KB | ||
| 2020-03-01 23:59 |
PledPharma places dosing of patients in the POLAR program on hold
|
English | 154.1 KB | ||
| 2020-02-18 08:00 | Swedish | 309.8 KB | |||
| 2020-02-18 08:00 | English | 310.6 KB | |||
| 2020-01-23 08:46 |
PledPharma provides update on the clinical POLAR program, clinical hold in the …
|
English | 74.4 KB | ||
| 2020-01-23 08:46 |
PledPharma uppdaterar gällande POLAR programmet, clinical hold i USA
|
Swedish | 77.5 KB | ||
| 2019-11-04 11:43 | English | 35.0 KB | |||
| 2019-10-31 08:17 |
Handeln i PledPharmas aktier inleds idag på Nasdaq Stockholms huvudlista
|
Swedish | 138.8 KB | ||
| 2019-10-31 08:17 |
Trading in PledPharma's shares commences today on the Nasdaq Stockholm main mar…
|
English | 124.2 KB |
Automate Your Workflow. Get a real-time feed of all Egetis Therapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Egetis Therapeutics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Egetis Therapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-09 | Yilmaz Mahshid | Other | Sell | 39,753 | 268,332.75 SEK |
| 2025-01-08 | Yilmaz Mahshid | Other | Sell | 98,567 | 653,499.21 SEK |
| 2025-01-07 | Yilmaz Mahshid | Other | Sell | 74,769 | 507,681.51 SEK |
| 2024-10-07 | Nicklas Westerholm | Other | Buy | 10,142 | 43,103.50 SEK |
| 2024-10-07 | Yilmaz Mahshid | Other | Buy | 10,000 | 42,250.00 SEK |
| 2023-07-07 | Henrik Krook | Other | Buy | 33,594 | 133,704.12 SEK |
| 2023-07-06 | Christian Sonesson | Other | Buy | 3,616 | 14,391.68 SEK |
| 2023-07-06 | Christian Sonesson | Other | Buy | 2,000 | 7,920.00 SEK |
| 2023-07-05 | Christian Sonesson | Other | Buy | 1,384 | 5,452.96 SEK |
| 2023-07-04 | Nicklas Westerholm | Other | Buy | 15,350 | 60,632.50 SEK |
Peer Companies
